Centers for Disease Control and Prevention (CDC):
The purpose of this Notice of Funding Opportunity (NOFO) is to support research to enable rapid and accurate identification of emerging vector-borne and zoonotic threats in Indonesia by building upon the scientific and laboratory infrastructure established under two previously awarded NOFOs. Indonesia is a recognized “hotspot” for emerging pathogens. It is the world’s fourth largest population, spread among nearly 1000 inhabited islands stretching 3,400 miles along the equator, making opportunities for an emerging pathogen to become epidemic in the absence of a reliable detection system high. The arthropod-borne viruses (arboviruses) and Rickettsia (typhus and spotted fevers) are of particular concern because of the ease with which vectors can transfer these viruses between wildlife, humans and livestock. Remarkably, little is known about these diseases in Indonesia or their potential for movement within and from the country. For example, only two of 11 pathogenic arboviruses known to be found in neighboring Australia have been identified in Indonesia. Although Indonesia is known historically to be endemic for murine typhus and scrub typhus, they are almost never diagnosed. CDC began a highly successful effort to build Indonesian capacity to identify emerging vector-borne diseases in 2011. This effort helped to (1) build and support a state-of-the-art molecular diagnostic laboratory at Jakarta; (2) conduct countrywide training in virological techniques and biosafety; and (3) pilot a large-scale acute febrile illness (AFI) surveillance network. During the previous cooperative agreement (RFA-CK-15-001), Indonesian and CDC partners identified the first West Nile and Zika virus cases in Indonesia, conducted the first Zika seroprevalence study, and identified Rickettsia felis for the first time as a cause of fatal neurological disease. Indonesia is a leader of the Global Health Security Agenda and the CDC mission supports Indonesia’s efforts to fulfill its Joint External Evaluation (JEE) goals; especially strengthening the national laboratory system and improving the ability of real-time surveillance in detecting emerging pathogens (WHO/OHE/2016.4, Indonesia JEE, November 2017).
- Awards: Up to $5,000,000 for 5 years.
- Deadlines: Due January 14, 2020
National Institutes of Health (NIH) – see limited submissions section below for additional NIH opportunities
Human-Animal Interaction (HAI) Research – PAR-20-031, R01 Research Project Grant
Human-Animal Interaction (HAI) Research – PAR-20-032, R03 Small Grant Program
Human-Animal Interaction (HAI) Research – PAR-20-033, R21 Exploratory/Developmental Grant
This Funding Opportunity Announcement (FOA) invites grant applications for research to examine 1) the impact of HAI on typical and atypical child development and health; 2) the evaluation of animal-assisted intervention for children and adults with disabilities or in need of rehabilitative services; 3) the effects of animals on public health, including cost effectiveness of involving animals in reducing and preventing disease.
- Awards: R01 – $500,000 direct costs per year for up to 5 years; R03 – $50,000 direct costs per year for 2 years; R21 – $275,000 total for up to 2 years.
- Deadlines: Letters of intent due November 20, 2019; Applications due December 20, 2019.
The purpose of this Funding Opportunity Announcement (FOA) is to encourage projects to generate fundamental knowledge of affective processes. Basic affective science projects should have key consequences for single (e.g., cancer screening) and multiple (e.g., adherence to oral chemotherapy regimen) event decisions and behaviors across the cancer prevention and control continuum. The FOA is expected to encourage collaboration among cancer control researchers and those from scientific disciplines not traditionally connected to cancer control applications (e.g., affective and cognitive neuroscience, decision science, consumer science) to elucidate perplexing and understudied problems in affective and decision sciences with downstream implications for cancer prevention and control.
- Awards: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
- Deadlines: Letters of intent due January 5, 2020; Applications due February 5, 2020.
National Science Foundation (NSF) – see limited submissions section below for additional NSF opportunities
The Division of Molecular and Cellular Biosciences (MCB) has developed a new opportunity to enable researchers with a strong track record of prior accomplishment to pursue a new avenue of research or inquiry. This funding mechanism is designed to facilitate and promote a PI’s ability to effective adopt empowering technologies that might not be readily accessible in the PI’s current research environment or collaboration network. Transformative research likely spans disciplines and minimizing the practical barriers to doing so will strengthen research programs poised to make significant contributions. The award is intended to allow mid-career or later-stage researchers (Associate or Full Professor, or equivalent) to expand or make a transition in their research programs via a sabbatical leave or similar mechanism of professional development and then develop that research program in their own lab. This award will also enable the PI to acquire new scientific or technical expertise, facilitate the investigator’s competitiveness, and potentially lead to transformational impacts in molecular and cellular bioscience. The award would fund up to six months of PI salary during the first sabbatical or professional development year, followed by support for continued research for two subsequent years upon the PI’s return to normal academic duties. Through this solicitation MCB and NSF hope to develop a novel mechanism that will encourage investigators to expand and/or transition to new research areas aligned with MCB priorities, to increase retention of investigators in science, and to ensure a diverse scientific workforce that remains engaged in active research.
Highest funding priority is given to proposals that have outstanding intellectual merit and broader impacts, while proposals with weaknesses in either category (or those that are perceived as likely to have an incremental impact) will not be competitive. Proposals should also demonstrate a strong record of prior accomplishment, a compelling plan for professional development that will enable the PI to forge a new direction in their scholarship, and a strong rationale for why this support is needed for the PI to become competitive in the new research area. Support for the proposed transition from the PI’s department, described in a letter from the department chair or equivalent, will also be required. Proposals that do not describe a plan for a transition in research direction will be considered unresponsive. Proposals that are motivated to understand the molecular and cellular basis of disease and disease treatments are not appropriate for the Division and will be returned without review. Proposals addressing major open questions at the intersections of biology with other disciplines, such as physics, chemistry, mathematics, computer sciences, and engineering are of particular interest to the program.
- Awards: Up to $750,000 total for 3 years.
- Deadlines: Proposals Accepted at Any Time.
Limited Submission Opportunities (https://vpr.tamu.edu/initiate-research/lsp):
|Program Name||Declaration of Intent Due
|NSF IUSE/Professional Formation of Engineers: Revolutionizing Engineering Departments (IUSE/PFE: RED)
|Brain Research Foundation 2020 Fay/Frank Seed Grants||11/01/2019||11/08/2019||01/07/2020|
|NIH Data Science Research: Personal Health Libraries for Consumers and Patients||11/1/2019||01/17/2020|
|NIH Initiative for Maximizing Student Development (IMSD) (T32)||10/30/2019||11/06/2019||01/28/2020|
|NSF Mid-Scale Innovations Program in Astronomical Sciences (MSIP)||10/29/2019||11/05/2019||12/19/2019*|
|NIH Collaborative Program Grant for Multidisciplinary Teams (RM1)||10/25/2019||11/01/2019||01/25/2020|
|HRSA State Offices of Rural Health Coordination and Development Program||10/22/2019||12/20/2019|
Grant Training Opportunities through TAMU Research Development Services:
OCTOBER 23 – 12:00PM
Participants in this interactive two-part workshop will have opportunity to provide and receive feedback on NIH Specific Aims pages, as well as receive feedback from experienced NIH peer reviewers. – Christina Howard
OCTOBER 24 – 1:30PM
Discussion with Q&A on planning and developing a multi-PI plan. Includes best practices for collaborative proposal development.
Register by October 23, 2019 at: https://tamu.qualtrics.com/jfe/form/SV_bvy15HNt1QQRpHL
Save the Date: AgriLife Lunch Seminar on Federal Budget Preparation
November 13, 11:30 am – 1:00 pm
PLPM 207 and via WebEx
Open to PI-eligible AgriLife faculty
Please mark your calendars for a lunchtime presentation and Q&A session with Sponsored Research Services and AgriLife Administrative Services. The topics covered will include allowable/unallowable costs, subawards/consultants, and cost share. Lunch is provided for in-person attendees who RSVP in advance. WebEx participation will also be available via RSVP. Full announcement and registration link to come.